Omniox Inc.

San Francisco, CA

UEI
MERZH84KMHM6
CAGE
4XAM9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
181 2nd St, San Francisco, CA 94105, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric… R44HD094414 National Institute of Child Health and Human Development (NIH) $7,221,896
Development of pet imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel h-NOX oxygen carrier R01CA204723 National Cancer Institute (NIH) $4,860,127
Reducing brain injury after focal ischemia using a nitric oxide-neutral oxygen carrier R44NS076272 National Institute of Neurological Disorders and Stroke (NIH) $2,324,448
Chemosensitizing hypoxic multiple myeloma with tunable, long-lived oxygen carriers R43CA192765 National Institutes of Health $280,141
Engineering of human h-NOX as an oxygen delivery therapeutic for prolonged admini R43CA177097 National Institutes of Health $225,000

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Omniox Inc. registered in SAM.gov?

Yes. Omniox Inc.'s SAM.gov registration is active through July 20, 2027.

What is Omniox Inc.'s most recent federal award?

Omniox Inc.'s most recent federal grant award is Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric… (R44HD094414), from National Institute of Child Health and Human Development (NIH), on August 1, 2017.

On GovTribe

See Omniox Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login